Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology …
Attention-deficit/hyperactivity disorder (ADHD) medication is one of the most commonly
prescribed medication classes in child and adolescent psychiatry, and its use is increasing …
prescribed medication classes in child and adolescent psychiatry, and its use is increasing …
Treatment of adult ADHD: a clinical perspective
J Geffen, K Forster - Therapeutic advances in …, 2018 - journals.sagepub.com
Adult attention deficit/hyperactivity disorder (ADHD) has moved from the blurred edge of
clinical focus to clear recognition as a prevalent and significant disorder in its own right. It is …
clinical focus to clear recognition as a prevalent and significant disorder in its own right. It is …
[图书][B] Adult ADHD: Diagnostic assessment and treatment
JJS Kooij - 2012 - books.google.com
Adult ADHD: Diagnostic Assessment and Treatment, Third Edition covers not only diagnostic
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support …
M Selfridge, K Card, T Kandler, E Flanagan… - International Journal of …, 2022 - Elsevier
Abstract Aims In March 2020, British Columbia issued Risk Mitigation Guidance (RMG) to
support prescribing of pharmaceutical alternatives to illicit drugs, in order to reduce risk for …
support prescribing of pharmaceutical alternatives to illicit drugs, in order to reduce risk for …
International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use …
H Özgen, R Spijkerman, M Noack… - European addiction …, 2020 - karger.com
Background: Childhood attention-deficit/hyperactivity disorder (ADHD) is a risk factor for
substance misuse and substance use disorder (SUD) in adolescence and (early) adulthood …
substance misuse and substance use disorder (SUD) in adolescence and (early) adulthood …
[HTML][HTML] The international collaboration on ADHD and substance abuse (ICASA): mission, results, and future activities
G Van de Glind, C Brynte, A Skutle, S Kaye… - European addiction …, 2020 - karger.com
Background: The International Collaboration on ADHD and Substance Abuse (ICASA) is a
network of 28 centers from 16 countries initiated to investigate the link between attention …
network of 28 centers from 16 countries initiated to investigate the link between attention …
[HTML][HTML] Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
G Więckiewicz, I Stokłosa, M Stokłosa… - Frontiers in …, 2023 - frontiersin.org
Introduction Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a
neurodevelopmental disorder that occurs mainly in children and tends to diminish or …
neurodevelopmental disorder that occurs mainly in children and tends to diminish or …
[HTML][HTML] Methylphenidate for attention-deficit and hyperactivity disorder in adult patients with substance use disorders: good clinical practice
S Chamakalayil, J Strasser, M Vogel, S Brand… - Frontiers in …, 2021 - frontiersin.org
Attention-deficit and hyperactivity disorder (ADHD) is a widespread neurodevelopmental
disorder in children and adolescents, persisting into adulthood in a majority of them. ADHD …
disorder in children and adolescents, persisting into adulthood in a majority of them. ADHD …
Trends in attention-deficit hyperactivity disorder diagnosis and pharmacotherapy among adults with opioid use disorder
Objective: This study aimed to assess nationwide trends in attention-deficit hyperactivity
disorder (ADHD) diagnoses and pharmacotherapy among patients with opioid use disorder …
disorder (ADHD) diagnoses and pharmacotherapy among patients with opioid use disorder …
[HTML][HTML] Remarkable reduction of cocaine use in dual disorder (adult attention deficit hyperactive disorder/cocaine use disorder) patients treated with medications for …
C Manni, G Cipollone, A Pallucchini… - International Journal of …, 2019 - mdpi.com
Background: Cocaine use disorder (CUD) is a growing public health concern, but so far no
effective pharmacotherapies have been demonstrated. Stimulant medications have proved …
effective pharmacotherapies have been demonstrated. Stimulant medications have proved …